| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $932.5M | -20.2% |
| Cost of Revenue | $681.9M | -15.0% |
| Gross Profit | $250.5M | -31.5% |
| R&D Expense | $88.4M | -4.9% |
| SG&A Expense | $56.3M | -5.6% |
| Operating Income | -$82.9M | -224.5% |
| Pre-tax Income | -$82.0M | -225.2% |
| Income Tax | -$13.0M | -180.9% |
| Net Income | -$69.0M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $146.5M | -44.5% |
| Short-term Investments | $80.9M | +945.0% |
| Accounts Receivable | $277.5M | +6.3% |
| Inventory | $299.6M | -5.1% |
| Current Assets | $834.3M | -5.5% |
| Total Assets | $1.02B | -5.4% |
| Current Liabilities | $346.0M | +1.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$13.7M | -199.9% |
| Capital Expenditures | $5.8M | -41.6% |
| Investing Cash Flow | -$79.5M | -696.4% |
| Financing Cash Flow | -$24.0M | +64.7% |
| Free Cash Flow | -$19.5M | -34.9% |
| -239.7% |
| EPS (Basic) | -$2.38 | -246.0% |
| EPS (Diluted) | -$2.38 | -249.7% |
| Total Liabilities |
| $398.9M |
| +4.5% |
| Stockholders' Equity | $620.9M | -10.9% |